Sequential occurrence of BCR::ABL1-negative MPN and CML and vice versa: results from a real world cohort. [PDF]
Schweneker K +6 more
europepmc +1 more source
The Silence of the Lambdas: Hidden Complexities in the Evolution of Double-Hit Lymphomas. [PDF]
Shevchenko G, Hodson DJ.
europepmc +1 more source
Targetable Vulnerabilities in MYC-Driven B Cell Lymphomas Resistant to BCR Extinction. [PDF]
Brambillasca S +15 more
europepmc +1 more source
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia. [PDF]
Benrashid S, Woyach JA.
europepmc +1 more source
Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation. [PDF]
Lugin ML +8 more
europepmc +1 more source
Kinase inhibition rewires the HLA-I immunopeptidome in chronic myeloid leukemia. [PDF]
Venafra V +10 more
europepmc +1 more source
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia. [PDF]
Hochhaus A +9 more
europepmc +1 more source
Ponatinib confers adult human cardiomyocyte toxicity via inhibition of AKT signaling. [PDF]
Guo L, Rao R, Liu H, Zhou B.
europepmc +1 more source
Targeting cell cycle in leukemia: "Is palbociclib the game-changer?": A review. [PDF]
Azizan MA +7 more
europepmc +1 more source
Roles of extracellular vesicles in the pathogenesis of chronic myeloid leukemia. [PDF]
Hrdinova T, Kupcova Skalnikova H.
europepmc +1 more source

